People · Operator
Named in public records as an officer, director or promoter · active 2014–2016 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| UVLrx Therapeutics, Inc. | — | Pharma | Pre-Seed | $980K | $9.7M | 2014 |
Michael Harter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Harter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rowland Hanson | 1 | 4 |
| Scott Grizzle | 1 | 2 |
| R. Scott Grizzle | 1 | 2 |
| Victor Scott Scheeren | 1 | 1 |
| Ryan Scott Maloney | 1 | 1 |
| Victor Sheeren | 1 | 1 |
| VICTOR SCHEEREN | 1 | 1 |
| Mitchell Wortzman | 1 | 1 |
| Tom DiGiovanni | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.